Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MODERN MEDICAL HALLLikely | - | 3 | ₹14,000 |
| 2 | Schedule 2 | MODERN MEDICAL HALLLikely | - | 2 | ₹1,080 |
| 3 | Schedule 3 | MODERN MEDICAL HALLLikely | - | 2 | ₹3,360 |
Tender Value
₹40,000
EMD Value
Exempted
Closing Date
26 Jul 2023, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Inj
5040279
GEM/2023/B/3699788
Two Packet Bid
Inj Denosumab 120 mg,Tab Letrozole 2.5 mg,Inj HPV
7 days
Punjab; Amritsar
Item wise evaluation
BOQ
4 documents required · 4 mandatory
60%
Exempted
26 Jul 2023
16 Jul 2023
26 Jul 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|---|
| 1 | Inj Denosumab 120 mg | Inj Denosumab 120 mg | 1 | Vial | Amritsar | 7 | |
| 2 | Tab Letrozole 2.5 mg | Tab Letrozole 2.5 mg | 90 | No | Amritsar | 7 | - |
| 3 | Inj HPV | Inj HPV Human Papiloma
Virus Quadrivalent
Vaccine recombinant | 1 | No | Amritsar | 7 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5040279.pdf
GEM_BID
med-spec_2023-07-16-10-42-24_282912f4b43837e2dc71a8bbc7ea9bc9.pdf
BOQ
boq-medici-1_2023-07-16-10-42-24_8509e96d1c3bb9a4db6955b75650f1f8.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .